HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS

The present invention relates to a compounds of general formula (I) inhibiting the JAK family of non-receptor tyrosine protein kinases (JAK1, JAK2, JAK3, and TYK2); methods of preparing such compounds, pharmaceutical compositions containing them and therapeutic use thereof. The compounds of the inve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ZIHER, DINKO, ACCETTA, ALESSANDRO, RANCATI, FABIO, BUTKOVIC, KRISTINA, CUZZOLIN, ALBERTO, ELENKOV, IVAYLO, MESIC, MILAN, RIZZI, ANDREA
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ZIHER, DINKO
ACCETTA, ALESSANDRO
RANCATI, FABIO
BUTKOVIC, KRISTINA
CUZZOLIN, ALBERTO
ELENKOV, IVAYLO
MESIC, MILAN
RIZZI, ANDREA
description The present invention relates to a compounds of general formula (I) inhibiting the JAK family of non-receptor tyrosine protein kinases (JAK1, JAK2, JAK3, and TYK2); methods of preparing such compounds, pharmaceutical compositions containing them and therapeutic use thereof. The compounds of the invention may be useful in the treatment of diseases or conditions associated with a dysregulation of the JAK family non-receptor kinases; in particular for the treatment of various inflammatory disease including asthma, COPD and other respiratory diseases. La présente invention concerne un composé de formule générale (I) inhibant la famille JAK des protéines kinases à tyrosine non réceptrices (JAK1, JAK2, JAK3 et TYK2) ; des procédés de préparation de tels composés, des compositions pharmaceutiques les contenant et leur utilisation thérapeutique. Les composés de l'invention peuvent être utiles dans le traitement de maladies ou d'états associés à un dérèglement des kinases non réceptrices de la famille JAK ; en particulier pour le traitement de diverses maladies inflammatoires, notamment l'asthme, la BPCO et d'autres maladies respiratoires.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3211584A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3211584A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3211584A13</originalsourceid><addsrcrecordid>eNrjZDD2cA1xDfJ3jnT28XRWcHEN8gxzDPEMcw1WcAxW8HL0Cw1W8Pb0cwx2VfD08_B08gzxDwrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxzo7GRoaGphYmjobGRCgBAGbvJr8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS</title><source>esp@cenet</source><creator>ZIHER, DINKO ; ACCETTA, ALESSANDRO ; RANCATI, FABIO ; BUTKOVIC, KRISTINA ; CUZZOLIN, ALBERTO ; ELENKOV, IVAYLO ; MESIC, MILAN ; RIZZI, ANDREA</creator><creatorcontrib>ZIHER, DINKO ; ACCETTA, ALESSANDRO ; RANCATI, FABIO ; BUTKOVIC, KRISTINA ; CUZZOLIN, ALBERTO ; ELENKOV, IVAYLO ; MESIC, MILAN ; RIZZI, ANDREA</creatorcontrib><description>The present invention relates to a compounds of general formula (I) inhibiting the JAK family of non-receptor tyrosine protein kinases (JAK1, JAK2, JAK3, and TYK2); methods of preparing such compounds, pharmaceutical compositions containing them and therapeutic use thereof. The compounds of the invention may be useful in the treatment of diseases or conditions associated with a dysregulation of the JAK family non-receptor kinases; in particular for the treatment of various inflammatory disease including asthma, COPD and other respiratory diseases. La présente invention concerne un composé de formule générale (I) inhibant la famille JAK des protéines kinases à tyrosine non réceptrices (JAK1, JAK2, JAK3 et TYK2) ; des procédés de préparation de tels composés, des compositions pharmaceutiques les contenant et leur utilisation thérapeutique. Les composés de l'invention peuvent être utiles dans le traitement de maladies ou d'états associés à un dérèglement des kinases non réceptrices de la famille JAK ; en particulier pour le traitement de diverses maladies inflammatoires, notamment l'asthme, la BPCO et d'autres maladies respiratoires.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220922&amp;DB=EPODOC&amp;CC=CA&amp;NR=3211584A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220922&amp;DB=EPODOC&amp;CC=CA&amp;NR=3211584A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZIHER, DINKO</creatorcontrib><creatorcontrib>ACCETTA, ALESSANDRO</creatorcontrib><creatorcontrib>RANCATI, FABIO</creatorcontrib><creatorcontrib>BUTKOVIC, KRISTINA</creatorcontrib><creatorcontrib>CUZZOLIN, ALBERTO</creatorcontrib><creatorcontrib>ELENKOV, IVAYLO</creatorcontrib><creatorcontrib>MESIC, MILAN</creatorcontrib><creatorcontrib>RIZZI, ANDREA</creatorcontrib><title>HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS</title><description>The present invention relates to a compounds of general formula (I) inhibiting the JAK family of non-receptor tyrosine protein kinases (JAK1, JAK2, JAK3, and TYK2); methods of preparing such compounds, pharmaceutical compositions containing them and therapeutic use thereof. The compounds of the invention may be useful in the treatment of diseases or conditions associated with a dysregulation of the JAK family non-receptor kinases; in particular for the treatment of various inflammatory disease including asthma, COPD and other respiratory diseases. La présente invention concerne un composé de formule générale (I) inhibant la famille JAK des protéines kinases à tyrosine non réceptrices (JAK1, JAK2, JAK3 et TYK2) ; des procédés de préparation de tels composés, des compositions pharmaceutiques les contenant et leur utilisation thérapeutique. Les composés de l'invention peuvent être utiles dans le traitement de maladies ou d'états associés à un dérèglement des kinases non réceptrices de la famille JAK ; en particulier pour le traitement de diverses maladies inflammatoires, notamment l'asthme, la BPCO et d'autres maladies respiratoires.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDD2cA1xDfJ3jnT28XRWcHEN8gxzDPEMcw1WcAxW8HL0Cw1W8Pb0cwx2VfD08_B08gzxDwrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxzo7GRoaGphYmjobGRCgBAGbvJr8</recordid><startdate>20220922</startdate><enddate>20220922</enddate><creator>ZIHER, DINKO</creator><creator>ACCETTA, ALESSANDRO</creator><creator>RANCATI, FABIO</creator><creator>BUTKOVIC, KRISTINA</creator><creator>CUZZOLIN, ALBERTO</creator><creator>ELENKOV, IVAYLO</creator><creator>MESIC, MILAN</creator><creator>RIZZI, ANDREA</creator><scope>EVB</scope></search><sort><creationdate>20220922</creationdate><title>HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS</title><author>ZIHER, DINKO ; ACCETTA, ALESSANDRO ; RANCATI, FABIO ; BUTKOVIC, KRISTINA ; CUZZOLIN, ALBERTO ; ELENKOV, IVAYLO ; MESIC, MILAN ; RIZZI, ANDREA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3211584A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ZIHER, DINKO</creatorcontrib><creatorcontrib>ACCETTA, ALESSANDRO</creatorcontrib><creatorcontrib>RANCATI, FABIO</creatorcontrib><creatorcontrib>BUTKOVIC, KRISTINA</creatorcontrib><creatorcontrib>CUZZOLIN, ALBERTO</creatorcontrib><creatorcontrib>ELENKOV, IVAYLO</creatorcontrib><creatorcontrib>MESIC, MILAN</creatorcontrib><creatorcontrib>RIZZI, ANDREA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZIHER, DINKO</au><au>ACCETTA, ALESSANDRO</au><au>RANCATI, FABIO</au><au>BUTKOVIC, KRISTINA</au><au>CUZZOLIN, ALBERTO</au><au>ELENKOV, IVAYLO</au><au>MESIC, MILAN</au><au>RIZZI, ANDREA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS</title><date>2022-09-22</date><risdate>2022</risdate><abstract>The present invention relates to a compounds of general formula (I) inhibiting the JAK family of non-receptor tyrosine protein kinases (JAK1, JAK2, JAK3, and TYK2); methods of preparing such compounds, pharmaceutical compositions containing them and therapeutic use thereof. The compounds of the invention may be useful in the treatment of diseases or conditions associated with a dysregulation of the JAK family non-receptor kinases; in particular for the treatment of various inflammatory disease including asthma, COPD and other respiratory diseases. La présente invention concerne un composé de formule générale (I) inhibant la famille JAK des protéines kinases à tyrosine non réceptrices (JAK1, JAK2, JAK3 et TYK2) ; des procédés de préparation de tels composés, des compositions pharmaceutiques les contenant et leur utilisation thérapeutique. Les composés de l'invention peuvent être utiles dans le traitement de maladies ou d'états associés à un dérèglement des kinases non réceptrices de la famille JAK ; en particulier pour le traitement de diverses maladies inflammatoires, notamment l'asthme, la BPCO et d'autres maladies respiratoires.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA3211584A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T04%3A53%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZIHER,%20DINKO&rft.date=2022-09-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3211584A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true